Lower Limb Multilevel Treatment With Drug-Eluting Balloons:6-Month Results From the DEBELLUM Randomized Trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1–75.
Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.N Engl J Med. 2008;358:689–699.
Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial.Circulation. 2008;118:1358–1365.
Scheller B. Opportunities and limitations of drug-coated balloons in interventional therapies.Herz. 2011;36:232–239.
Chan YC, Cheng SW. Drug-eluting stents and balloons in peripheral arterial disease: evidence so far.Int J Clin Pract. 2011;65:664–668.
Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.Circ Cardiovasc Interv. 2011;4:495–504.
Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome.J Am Coll Cardiol. 2011;58:1105–1109.
Feiring AJ, Krahn M, Nelson L, et al. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial.J Am Coll Cardiol. 2010;55:1580–1589.
Balzer JO, Zeller T, Rastan A, et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents.J Cardiovasc Surg (Torino). 2010;51:183–191.
Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.J Vasc Surg. 2012;55:390–398.
Mauri L, Orav EJ, Candia SC, et al. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.Circulation. 2005;112:2833–2939.
Baumann F, Willenberg T, Do DD, et al. Endovascular revascularization of below-the-knee arteries: prospective short-term angiographic and clinical follow-up.J Vasc Interv Radiol. 2011;22:1665–1673.
Sharma S, Kukreja N, Christopoulos C, et al. Drug-eluting balloon: new tool in the box.Expert Rev Med Devices. 2010;7:381–388.
Cremers B, Speck U, Kaufels N, et al. Drug-eluting balloon: very short-term exposure and overlapping.Thromb Haemost. 2009;101:201–206.
Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.Circulation. 2004;110:810–814.
Micari A, Cioppa A, MD, Vadalà G, et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease. 12-month results from a multicenter Italian Registry.JACC Cardiovasc Interv. 2012;5:331–338.
Zeller T, Schmitmeier S, Tepe G, et al. Drug-coated balloons in the lower limb.J Cardiovasc Surg (Torino). 2011;52:235–243.
Werk M, Albrecht T, Meyer DR, et al. The PACIFIER trial: a randomized multicenter trial evaluating prevention of restenosis with paclitaxel-coated PTA balloon catheters in stenosis or occlusion of femoropopliteal arteries. Presented at LINC 2012 held in Leipzig, Germany, January 25–28, 2012. Available at:http://www.leipzig-interventional-course.com/index.php? option=com_docman&task=doc_download&gid=1053. Last accessed June 6, 2012.